Biblio
Advancements in personalized stem cell models for aging-related neurodegenerative disorders. Neural Regen Res. 2024;19(11):2333-2334.
. Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17. FEBS J. 2019.
. The chromatin accessibility landscape reveals distinct transcriptional regulation in the induction of human primordial germ cell-like cells from pluripotent stem cells. Stem Cell Reports. 2021.
An engineered Sox17 induces somatic to neural stem cell fate transitions independently from pluripotency reprogramming. Sci Adv. 2023;9(34):eadh2501.
Evaluation of the determinants for improved pluripotency induction and maintenance by engineered SOX17. Nucleic Acids Res. 2023.
. glbase: a framework for combining, analyzing and displaying heterogeneous genomic and high-throughput sequencing data. Cell Regen (Lond). 2014;3(1):1.
. Highly cooperative chimeric super-SOX induces naive pluripotency across species. Cell Stem Cell. 2023.
OCT4: A penetrant pluripotency inducer. Cell Regen (Lond). 2014;3(1):6.
. Restricting epigenetic activity promotes the reprogramming of transformed cells to pluripotency in a line-specific manner. Cell Death Discov. 2023;9(1):245.
Sox transcription factors require selective interactions with Oct4 and specific transactivation functions to mediate reprogramming. Stem Cells. 2013.
. SOX17 in cellular reprogramming and cancer. Semin Cancer Biol. 2019.
. .